These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 1320051

  • 1. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone.
    Oelkers W, Diederich S, Bähr V.
    J Clin Endocrinol Metab; 1992 Jul; 75(1):259-64. PubMed ID: 1320051
    [Abstract] [Full Text] [Related]

  • 2. Effects of fludrocortisone withdrawal on plasma angiotensin II, ACTH, vasopressin, and potassium in patients with Addison's disease.
    Oelkers W, Bähr V.
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):325-30. PubMed ID: 3039766
    [Abstract] [Full Text] [Related]

  • 3. Adrenocortical dysfunction in paracoccidioidomycosis: comparison between plasma beta-lipotrophin/adrenocorticotrophin levels and adrenocortical tests.
    Moreira AC, Martinez R, Castro M, Elias LL.
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):545-51. PubMed ID: 1330381
    [Abstract] [Full Text] [Related]

  • 4. Mineralocorticoid substitution and monitoring in primary adrenal insufficiency.
    Quinkler M, Oelkers W, Remde H, Allolio B.
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):17-24. PubMed ID: 25617169
    [Abstract] [Full Text] [Related]

  • 5. Addison's disease.
    Nieman LK, Chanco Turner ML.
    Clin Dermatol; 2006 Jan; 24(4):276-80. PubMed ID: 16828409
    [Abstract] [Full Text] [Related]

  • 6. Primary vs secondary adrenal insufficiency: ACTH-stimulated aldosterone diagnostic cut-off values by tandem mass spectrometry.
    Abraham SB, Abel BS, Sinaii N, Saverino E, Wade M, Nieman LK.
    Clin Endocrinol (Oxf); 2015 Sep; 83(3):308-14. PubMed ID: 25620457
    [Abstract] [Full Text] [Related]

  • 7. [Effect of furosemide and ACTH on plasma renin, aldosterone and cortisol levels in normal man].
    Cénac A, London A, Ménard J, Corvol P.
    Ann Endocrinol (Paris); 1975 Sep; 36(3):153-62. PubMed ID: 172005
    [Abstract] [Full Text] [Related]

  • 8. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
    Cohen N, Gilbert R, Wirth A, Casley D, Jerums G.
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1411-5. PubMed ID: 8636343
    [Abstract] [Full Text] [Related]

  • 9. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin.
    Contreras LN, Arregger AL, Persi GG, Gonzalez NS, Cardoso EM.
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):675-82. PubMed ID: 15579180
    [Abstract] [Full Text] [Related]

  • 10. The effect of dexamethasone on the control of plasma aldosterone concentration in normal recumbent man.
    Weinberger MH, Kem DC, Gomez-Sanchez C, Kramer NJ, Martin BT, Nugent CA.
    J Lab Clin Med; 1975 Jun; 85(6):957-67. PubMed ID: 166119
    [Abstract] [Full Text] [Related]

  • 11. [Extended ACTH rapid test for differentiation of primary and secondary adrenal insufficiency].
    Albert JP, Schirmer A, Hartmann F.
    Med Klin; 1980 Sep 12; 75(19):693-6. PubMed ID: 6253778
    [Abstract] [Full Text] [Related]

  • 12. Control of mineralocorticoid substitution in Addison's disease by plasma renin measurement.
    Oelkers W, L'age M.
    Klin Wochenschr; 1976 Jul 01; 54(13):607-12. PubMed ID: 940296
    [Abstract] [Full Text] [Related]

  • 13. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA, Livesey JH, Florkowski C, Or HK, Donald RA, Espiner EA.
    J Clin Endocrinol Metab; 1993 Jan 01; 76(1):192-6. PubMed ID: 8380605
    [Abstract] [Full Text] [Related]

  • 14. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec 01; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 15. Tuberculous Addison's disease: lack of normalization of adrenocortical function after anti-tuberculous chemotherapy.
    Bhatia E, Jain SK, Gupta RK, Pandey R.
    Clin Endocrinol (Oxf); 1998 Mar 01; 48(3):355-9. PubMed ID: 9578827
    [Abstract] [Full Text] [Related]

  • 16. The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency.
    Flad TM, Conway JD, Cunningham SK, McKenna TJ.
    Clin Endocrinol (Oxf); 1996 Nov 01; 45(5):529-34. PubMed ID: 8977748
    [Abstract] [Full Text] [Related]

  • 17. Renin, angiotensin, corticosteroids, and electrolyte balance in Addison's disease.
    Brown JJ, Fraser R, Lever AF, Robertson JI, James VH, McCusker J, Wynn V.
    Q J Med; 1968 Jan 01; 37(145):97-118. PubMed ID: 4297956
    [No Abstract] [Full Text] [Related]

  • 18. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
    Nakahara M, Shibasaki T, Shizume K, Kiyosawa Y, Odagiri E, Suda T, Yamaguchi H, Tsushima T, Demura H, Maeda T.
    J Clin Endocrinol Metab; 1983 Nov 01; 57(5):963-8. PubMed ID: 6311867
    [Abstract] [Full Text] [Related]

  • 19. Assessment of adrenal function in women heterozygous for adrenoleukodystrophy.
    el-Deiry SS, Naidu S, Blevins LS, Ladenson PW.
    J Clin Endocrinol Metab; 1997 Mar 01; 82(3):856-60. PubMed ID: 9062496
    [Abstract] [Full Text] [Related]

  • 20. Mineralocorticoid replacement in Addison's disease.
    Thompson DG, Mason AS, Goodwin FJ.
    Clin Endocrinol (Oxf); 1979 May 01; 10(5):499-506. PubMed ID: 476980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.